首页> 美国卫生研究院文献>Bioinformation >Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model
【2h】

Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model

机译:使用基于受体的药效团模型对HIV-1整合酶抑制剂进行计算筛选

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The HIV (human immuno­deficiency virus) integrase has a crucial role in viral replication. Moreover, it has no cellular homologue in humans. Hence, it is considered as an attractive drug target. Many inhibitors against the integrase protein has been designed and discussed. The Y-3 inhibitor (4-acetyl amino-5-hydroxy naphthalene - 2, 7- disulfonic acid) is already known to inhibit HIV-1 integrase. However, it is not suitable as a drug like candidate due to its high cyto-toxicity. In this report, a pharmacophore model for HIV integrase is described using the already known Y-3 inhibitor binding site. Fourteen compounds chemically related to the Y-3 inhibitor were generated using the described pharmacophore model and reported. Subsequent computational analysis showed that these compounds have interactions with the Y3 binding site and their possible utility as an integrase inhibitor is discussed.
机译:HIV(人类免疫缺陷病毒)整合酶在病毒复制中具有至关重要的作用。而且,它在人类中没有细胞同源物。因此,它被认为是有吸引力的药物靶标。已经设计和讨论了许多针对整合酶蛋白的抑制剂。已知Y-3抑制剂(4-乙酰氨基-5-羟基萘-2、7-二磺酸)可抑制HIV-1整合酶。但是,由于其高细胞毒性,因此不适合作为候选药物。在此报告中,使用已知的Y-3抑制剂结合位点描述了HIV整合酶的药效团模型。使用所述药效团模型产生了与Y-3抑制剂化学相关的14种化合物,并进行了报道。随后的计算分析表明,这些化合物与Y3结合位点具有相互作用,并讨论了它们作为整合酶抑制剂的可能用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号